US143164A - Improvement in medical compounds or opium-cures - Google Patents
Improvement in medical compounds or opium-cures Download PDFInfo
- Publication number
- US143164A US143164A US143164DA US143164A US 143164 A US143164 A US 143164A US 143164D A US143164D A US 143164DA US 143164 A US143164 A US 143164A
- Authority
- US
- United States
- Prior art keywords
- opium
- cures
- improvement
- medical compounds
- morphia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
Definitions
- Opiumfiure a certain Medical Compound, called Opiumfiure, to be used as a specific remedy for the cure of the opium mania, or what is usually called and known as the opium habit, and to relieve the pain and suffering usually occasioned by the long-continued use of opiates; and to enable that class of persons called opium'eaters to abandon the habit and discontinue the use of morphia or any preparation of opium; also, to be used for the cure of delirium tremens, and such other affections of the brain and nervous system as may be caused by the excessive use of opium or any preparation thereof, or of alcoholic drinks.
- My invention consists in combining the active principle of wild lettuce, (Lactucin Salu- 0a, and adding thereto a tincture of bitter almonds when desirable, as hereinafter describedthat is to say, to one pound of the fluid extract of Wild lettuce (Lactucct elongate) I add one-half ounce of lactucin and onefourth ounce of salucin. To this compound I add, when desirable, one ounce of the tincture of bitter almonds. These proportions may be varied somewhat Without materially detracting from the virtues of my remedy; but, for general use and most efficient action,
- the compound may be prepared, if desirable, in the form of pills; but, as a general rule, I prefer to use it as a solution.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
UNITED STATES ULYSSES H. KELLOGG, OF JAMESTOWN, NEW YORK.
IMPROVEMENT IN MEDICAL COMPOUNDS OR OPlUM-CURES.
Specification forming part of Letters Patent No. 143,] 641, dated September 23, 1873 application filed August 9, 1873.
To all whom it may concern:
Be it known that I, ULYSSES H. KELLOGG, of Jamestown, county of Chautauqua and State of New York, have invented a certain Medical Compound, called Opiumfiure, to be used as a specific remedy for the cure of the opium mania, or what is usually called and known as the opium habit, and to relieve the pain and suffering usually occasioned by the long-continued use of opiates; and to enable that class of persons called opium'eaters to abandon the habit and discontinue the use of morphia or any preparation of opium; also, to be used for the cure of delirium tremens, and such other affections of the brain and nervous system as may be caused by the excessive use of opium or any preparation thereof, or of alcoholic drinks.
My invention consists in combining the active principle of wild lettuce, (Lactucin Salu- 0a, and adding thereto a tincture of bitter almonds when desirable, as hereinafter describedthat is to say, to one pound of the fluid extract of Wild lettuce (Lactucct elongate) I add one-half ounce of lactucin and onefourth ounce of salucin. To this compound I add, when desirable, one ounce of the tincture of bitter almonds. These proportions may be varied somewhat Without materially detracting from the virtues of my remedy; but, for general use and most efficient action,
I recommend the formula above given. The compound may be prepared, if desirable, in the form of pills; but, as a general rule, I prefer to use it as a solution.
For a'person in the habit of using ten grains of sulphate of morphia per day, give two fluid drains three times per day; and for persons using more or less, in same proportion, or a quantity suflicient to prevent suffering in consequence of ceasing to use morphia. In cases of the most extreme nature, when the mind is badly affected and the patient is inclined to be delirious, one-eighth of the usual quantity of morphia should be continued for from five to ten days, or until all signs of mental derangement disappear, after which time the quantity of the opium-cure is gradually reduced, and as soon as the opium or morphia becomes eliminated from the system the use of the opium-cure may be discontinued.
I claim as my invention- 1. The combination of Lactucct clongata, lactucin, and salucin, with or Without a tincture of bitter almonds, substantially as specified.
2. The medical compound described, substantially as and for the purpose specified.
ULYSSES H. KELLOGG.
Witnesses:
EDWARD R. BOOTY, F. 1). BALDWIN.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US143164A true US143164A (en) | 1873-09-23 |
Family
ID=2212577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US143164D Expired - Lifetime US143164A (en) | Improvement in medical compounds or opium-cures |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US143164A (en) |
-
0
- US US143164D patent/US143164A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baratloo et al. | The role of caffeine in pain management: a brief literature review | |
| Grinspoon et al. | Coca and cocaine as medicines: an historical review | |
| CN109846862A (en) | Combination therapy for Alzheimer's disease and related diseases | |
| WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
| Dettmeyer et al. | Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases | |
| Lepola et al. | Citalopram in the treatment of early-onset panic disorder and school phobia | |
| Kumar et al. | Antidepresant activity of Indian Hypericum perforatum Linn in rodents | |
| US143164A (en) | Improvement in medical compounds or opium-cures | |
| KR102005887B1 (en) | Pharmaceutical composition for preventing or treating brain tumor | |
| KR101756688B1 (en) | Composition for anti-pancreatic cancer agent or anti-pancreatic cancer supplement agent using Fraxinellone | |
| Tewari et al. | Galanthus nivalis L.(snowdrop) | |
| Frazzetto | Does marijuana have a future in pharmacopoeia? | |
| Iiarl | Oral anticoagulants for secondary prevention of stroke | |
| CA2139896C (en) | Use of antinauseant agent for terminally ill humans | |
| Takahama et al. | Anaphylaxis due to levofloxacin. | |
| Clayton et al. | Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate | |
| AR052191A1 (en) | TREATMENT METHOD | |
| D’Erme et al. | Antihistamines | |
| Lee et al. | Suzetrigine: A Novel, Peripherally Acting Analgesic | |
| Olive | Central Texas Medical Society | |
| US116310A (en) | Improvement in medical compounds or bitters | |
| Tan et al. | Control of emsis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide | |
| US203965A (en) | Improvement in medical compounds | |
| Mohite et al. | Comparative assessment of nootropic activity of Yashtimadhu Choorna and Yashtimadhu Kshirapaka in young and aged mice | |
| LOURIA | II. ABUSE OF LYSERGIC ACID DIETHYLAMIDE—AN INCREASING PROBLEM |